Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)

Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease

Status

Terminated

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00205062

Enrollment

Unknown

Registered

2005-09-20

Start date

2004-10-31

Completion date

2008-08-31

Last updated

2015-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

The main hypothesis is that PET-CT will be a valuable diagnostic tool in diagnosing and evaluating treatment for IBD.

Interventions

PROCEDUREPET-CT

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with either Crohn's disease or ulcerative colitis whose disease is flaring

Exclusion criteria

* Indeterminate diagnosis, pregnant, breastfeeding, or other contraindication to PET-CT

Design outcomes

Primary

Measure	Time frame
Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?	—

Secondary

Measure	Time frame
Does this technique provide additional information for practitioners on extent of disease?	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026